Privia Health Group (NASDAQ:PRVA) Coverage Initiated by Analysts at Macquarie

Equities research analysts at Macquarie began coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research note issued on Monday, MarketBeat.com reports. The firm set an “outperform” rating and a $25.00 price target on the stock. Macquarie’s price target would indicate a potential upside of 20.25% from the stock’s previous close.

Several other equities analysts have also issued reports on the company. KeyCorp initiated coverage on Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price on the stock. Truist Financial increased their price objective on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. JPMorgan Chase & Co. increased their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Robert W. Baird boosted their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 26th. Finally, Barclays lifted their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $24.80.

Privia Health Group Stock Performance

Shares of PRVA opened at $20.79 on Monday. The company has a 50 day moving average price of $20.12 and a 200-day moving average price of $19.10. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $24.30. The stock has a market capitalization of $2.49 billion, a PE ratio of 207.92, a PEG ratio of 5.45 and a beta of 0.83.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. FMR LLC raised its position in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after acquiring an additional 271,645 shares during the period. Geode Capital Management LLC increased its stake in shares of Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock valued at $43,986,000 after purchasing an additional 23,178 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after purchasing an additional 28,480 shares in the last quarter. Millennium Management LLC raised its holdings in Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after purchasing an additional 1,101,730 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Privia Health Group by 18.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after purchasing an additional 173,934 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.